Jackson Financial

JXNNYSEUSD

THESIS ALERT

Email me when the JXN thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$138.63
−$0.81 (−0.58%)Today 1M +5.60%
After hours$138.630.00%

Updated Nov 12, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$139.44
Prior regular-session close from the quote source.
$138.34–$140.50
Regular-session low and high so far today.
456.1K
Regular-session shares traded · Nov 12, 4:00 PM ET.
Feb 17 projected
Projected for 2027-02-17 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$89.67–$150.00
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own JXN if Jackson is a capital-generative life-insurance holding company whose value to shareholders depends less on volatile GAAP earnings and more on the ability of regulated insurance subsidiaries to produce stable operating cash flow that can.

JXN price history

Latest price$138.63Today−$0.81 (-0.58%)
JXN +5.17%S&P 500 -2.67%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

3 MATERIAL PROPOSITIONS
  • Jackson’s shareholder returns (dividends and buybacks) are sustainable so long as its insurance subsidiaries continue to generate stable operating cash flow and regulators permit ordinary distributions.StrengtheningMateriality: High

    NetCashProvidedByUsedInOperatingActivities = 5,758,000,000 USD (annual, 2025). If true, shareholders get continuing buybacks/dividends funded by cash generation even when GAAP earnings swing; if false, the parent loses its distribution channel and the stock will likely de-rate.

    Watch: State insurance regulators (e.g., Michigan Director of Insurance, NY DFS) limiting or denying ordinary or extraordinary dividends.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    NetCashProvidedByUsedInOperatingActivities = 5,758,000,000 USD (annual, 2025).

    Open source ↗
  • GAAP net income will remain a noisy indicator of Jackson’s economic cash generation because investment-related realized/unrealized gains and actuarial/reserve items drive large swings in reported earnings.StrengtheningMateriality: High

    NetIncomeLoss = 6,186,000,000 USD (annual, 2022) then 899,000,000 USD (2023), 902,000,000 USD (2024) and -17,000,000 USD (2025) — large year-to-year swings. Relying on GAAP net income alone misleads investors about distributable cash and the company’s ability to fund buybacks/dividends; cash metrics and statutory capital matter more.

    Watch: A strategic pivot toward fee-based or less market-sensitive products (reducing investment-return volatility).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    NetIncomeLoss = 6,186,000,000 USD (annual, 2022) then 899,000,000 USD (2023), 902,000,000 USD (2024) and -17,000,000 USD (2025) — large year-to-year.

    Open source ↗
  • Regulatory permission (state insurance commissioners, FSOC/Fed) to pay ordinary and extraordinary dividends is the single critical moat: if regulators curtail distributions, Jackson’s parent-level capital return engine is effectively shut off.HoldingMateriality: Medium

    MD&A discussion that dividends may be limited by state insurance laws, that Michigan and New York regulators can restrict payments, and that distributions above statutory amounts require regulatory approval. The company’s ability to monetize its cash-generative subsidiaries for shareholders depends on regulators continuing to permit distributions — loss of permission would force capital retention and a material re-rating.

    Watch: FSOC designation as systemically important or heightened Federal Reserve regulation that imposes strict limits on parent distributions.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A discussion that dividends may be limited by state insurance laws, that Michigan and New York regulators can restrict payments.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Jackson’s shareholder returns (dividends and buybacks) are sustainable so long as its insurance subsidiaries continue to generate stable operating cash flow and regulators permit ordinary distributions. If true, shareholders get continuing buybacks/dividends funded by cash generation even when GAAP earnings swing; if false, the parent loses its distribution channel and the stock will likely de-rate.

GAAP net income will remain a noisy indicator of Jackson’s economic cash generation because investment-related realized/unrealized gains and actuarial/reserve items drive large swings in reported earnings. Relying on GAAP net income alone misleads investors about distributable cash and the company’s ability to fund buybacks/dividends; cash metrics and statutory capital matter more.

Regulatory permission (state insurance commissioners, FSOC/Fed) to pay ordinary and extraordinary dividends is the single critical moat: if regulators curtail distributions, Jackson’s parent-level capital return engine is effectively shut off. The company’s ability to monetize its cash-generative subsidiaries for shareholders depends on regulators continuing to permit distributions — loss of permission would force capital retention and a material re-rating.

All standing thesis claims
Original report summary

Jackson is a capital-generative life-insurance holding company whose value to shareholders depends less on volatile GAAP earnings and more on the ability of regulated insurance subsidiaries to produce stable operating cash flow that can.

Evidence assessed Nov 10, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Jackson Financial

Where the evidence on Jackson Financial stands: Holding on the latest evidence (Nov 10, 2026). Of its 3 thesis points, 2 strengthening and 1 holding.

Bull case: what the evidence supports

  • Jackson’s shareholder returns (dividends and buybacks) are sustainable so long as its insurance subsidiaries continue to generate stable operating cash flow and regulators permit ordinary distributions.

    sec.gov ↗

  • GAAP net income will remain a noisy indicator of Jackson’s economic cash generation because investment-related realized/unrealized gains and actuarial/reserve items drive large swings in reported earnings.

    sec.gov ↗

  • Regulatory permission (state insurance commissioners, FSOC/Fed) to pay ordinary and extraordinary dividends is the single critical moat: if regulators curtail distributions, Jackson’s parent-level capital return engine is effectively shut off.

    sec.gov ↗

Bear case: what would count against it

  • State insurance regulators (e.g., Michigan Director of Insurance, NY DFS) limiting or denying ordinary or extraordinary dividends.

    sec.gov ↗

  • A strategic pivot toward fee-based or less market-sensitive products (reducing investment-return volatility).

    sec.gov ↗

  • FSOC designation as systemically important or heightened Federal Reserve regulation that imposes strict limits on parent distributions.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Jackson Financial

OptimistFi is watching Jackson Financial. No break-condition checks are on record yet — they accumulate as new filings are checked.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Jackson Financial filed an SEC 8-K on 2026-11-03: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Regulation FD disclosure.

    Jackson Financial filed an SEC 8-K on 2026-11-03: Regulation FD disclosure. It is a dated development that tests the current thesis.

  3. Mixed
    Director or principal officer change.

    Jackson Financial filed an SEC 8-K on 2026-10-14: Director or principal officer change. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • State insurance regulators (e.g., Michigan Director of Insurance, NY DFS) limiting or denying ordinary or extraordinary dividends.
  • A strategic pivot toward fee-based or less market-sensitive products (reducing investment-return volatility).
  • FSOC designation as systemically important or heightened Federal Reserve regulation that imposes strict limits on parent distributions.

JXN news

Loading headlines…

Financial statements

JXN income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

JXN: quick answers

When does Jackson Financial (JXN) report earnings next?
Jackson Financial's next results are projected for February 17, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 3, 2026. Earnings calendar
What is JXN's short interest?
As of October 30, 2026, 3.2M JXN shares were sold short, 4.82% of its shares outstanding, down 10.8% from the count before. At the stock's average daily volume that is 4.6 days to cover. FINRA publishes the count twice a month. JXN short interest history
Which well-known investors own JXN?
2 of the 37 well-known funds tracked here reported JXN shares in their latest 13F filings. By share of the fund's portfolio: Miller Value Partners (Bill Miller), 1.9%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

JXN in well-known investors’ portfolios

2 of 37 funds reported JXN shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Bill MillerMiller Value Partners1.9%$8.2M−0.7%Q2 2026
Ray DalioBridgewater Associates0.03%$7.1M−21.7%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.